Antigens, Tumor-Associated, Carbohydrate

"Antigens, Tumor-Associated, Carbohydrate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies.

Descriptor ID	D015295
MeSH Number(s)	D23.050.285.050 D23.050.550.325 D23.101.140.075
Concept/Terms	Antigens, Tumor-Associated, Carbohydrate Antigens, Tumor-Associated, Carbohydrate Carbohydrate Antigens, Tumor-Associated Antigens, Tumor-Associated Carbohydrate Carbohydrate Antigens, Tumor Associated Tumor-Associated Carbohydrate Antigens Tumor Associated Carbohydrate Antigens CA Antigen Antigen, CA Epitectin CA(Oxford) Antigen Cancer-Associated Carbohydrate Antigens Antigens, Cancer-Associated Carbohydrate Cancer Associated Carbohydrate Antigens Carbohydrate Antigens, Cancer-Associated Antigen, Carcinoma-Associated Antigen, Carcinoma Associated Carcinoma-Associated Antigen Carcinoma Associated Antigen Antigens, Carbohydrate, Tumor-Associated CA Antigens Antigens, CA

Below are MeSH descriptors whose meaning is more general than "Antigens, Tumor-Associated, Carbohydrate".

Chemicals and Drugs [D]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Neoplasm [D23.050.285]
Antigens, Tumor-Associated, Carbohydrate [D23.050.285.050]
Epitopes [D23.050.550]
Antigens, Tumor-Associated, Carbohydrate [D23.050.550.325]
Biomarkers [D23.101]
Biomarkers, Tumor [D23.101.140]
Antigens, Tumor-Associated, Carbohydrate [D23.101.140.075]

Below are MeSH descriptors whose meaning is related to "Antigens, Tumor-Associated, Carbohydrate".

Below are MeSH descriptors whose meaning is more specific than "Antigens, Tumor-Associated, Carbohydrate".

Antigens, Tumor-Associated, Carbohydrate
CA-125 Antigen
CA-19-9 Antigen
Lewis X Antigen
Mucin-1

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antigens, Tumor-Associated, Carbohydrate" by people in this website by year, and whether "Antigens, Tumor-Associated, Carbohydrate" was a major or minor topic of these publications.

Bar chart showing 7 publications over 5 distinct years, with a maximum of 2 publications in 1993 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	1	1	2
1995	0	1	1
2017	1	0	1
2019	1	0	1
2020	1	1	2

Below are the most recent publications written about "Antigens, Tumor-Associated, Carbohydrate" by people in Profiles.

McDowell CT, Klamer Z, Hall J, West CA, Wisniewski L, Powers TW, Angel PM, Mehta AS, Lewin DN, Haab BB, Drake RR. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues. Mol Cell Proteomics. 2021; 20:100012.

View in: PubMed
Gao C, Wisniewski L, Liu Y, Staal B, Beddows I, Plenker D, Aldakkak M, Hall J, Barnett D, Gouda MK, Allen P, Drake R, Zureikat A, Huang Y, Evans D, Singhi A, Brand RE, Tuveson DA, Tsai S, Haab BB. Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. Clin Cancer Res. 2021 01 01; 27(1):226-236.

View in: PubMed
Staal B, Liu Y, Barnett D, Hsueh P, He Z, Gao C, Partyka K, Hurd MW, Singhi AD, Drake RR, Huang Y, Maitra A, Brand RE, Haab BB. The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. Clin Cancer Res. 2019 05 01; 25(9):2745-2754.

View in: PubMed
Barnett D, Liu Y, Partyka K, Huang Y, Tang H, Hostetter G, Brand RE, Singhi AD, Drake RR, Haab BB. The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. Sci Rep. 2017 06 22; 7(1):4020.

View in: PubMed
Dasgupta S, Hogan EL, van Halbeek H. Chemical and immunological characterization of galactosyl-beta 1-3-globoside in bovine, human, and rat brain. J Neurochem. 1995 Nov; 65(5):2344-9.

View in: PubMed
Wong JG, Feussner JR. Screening for ovarian cancer: not worthwhile for most patients. N C Med J. 1993 Sep; 54(9):438-40.

View in: PubMed
Helzlsouer KJ, Bush TL, Alberg AJ, Bass KM, Zacur H, Comstock GW. Prospective study of serum CA-125 levels as markers of ovarian cancer. JAMA. 1993 Mar 03; 269(9):1123-6.

View in: PubMed
Bast RC, Knauf S, Epenetos A, Dhokia B, Daly L, Tanner M, Soper J, Creasman W, Gall S, Knapp RC, et al. Coordinate elevation of serum markers in ovarian cancer but not in benign disease. Cancer. 1991 Oct 15; 68(8):1758-63.

View in: PubMed
Soper JT, Hunter VJ, Daly L, Tanner M, Creasman WT, Bast RC. Preoperative serum tumor-associated antigen levels in women with pelvic masses. Obstet Gynecol. 1990 Feb; 75(2):249-54.

View in: PubMed
Mahvi DM, Seigler HF, Meyers WC, Kalthoff H, Schmiegel WH, Metzgar RS. DU-PAN-2 levels in serum and pancreatic ductal fluids of patients with benign and malignant pancreatic disease. Pancreas. 1988; 3(4):488-93.

View in: PubMed

People

Explore

Similar Concepts

Top Journals